Presentation of IFN-γ to nitric oxide-producing cells:: A novel function for mast cells

被引:33
作者
Brooks, B
Briggs, DM
Eastmond, NC
Fernig, DG
Coleman, JW [1 ]
机构
[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England
[2] Univ Liverpool, Sch Biol Sci, Liverpool L69 3GE, Merseyside, England
关键词
D O I
10.4049/jimmunol.164.2.573
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report that mast cells can bind and present IFN-gamma in a functionally active form to macrophages. Flow-cytometric analysis revealed that biotinylated IFN-gamma bound equally well to purified peritoneal mast cells from both IFN-gamma R knockout and wild-type mice, indicating a non-IFN-gamma R binding site. Purified peritoneal mast cells, loaded with IFN-gamma for 30 min and washed, were able to induce NO synthesis by peritoneal macrophages. This response required cell contact and expression of IFN-gamma R on the responding macrophages, but not the mast cells. Human HMC-1 mast cells were also able to present IFN-gamma to mouse macrophages. Enzyme treatment of mouse mast cells revealed that binding of IFN-gamma was predominantly to chondroitin sulfate B (dermatan sulfate). Binding of IFN-gamma to dermatan sulfate was confirmed by inhibition ELISA. This study demonstrates for the first time that mast cells can present IFN-gamma to other cells via glycosaminoglycans. Mast cells may act as a reservoir of surface-stored functionally active cytokines.
引用
收藏
页码:573 / 579
页数:7
相关论文
共 50 条
[1]   Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration [J].
Anderson, DF ;
MacLeod, JDA ;
Baddeley, SM ;
Bacon, AS ;
McGill, JI ;
Holgate, ST ;
Roche, WR .
CLINICAL AND EXPERIMENTAL ALLERGY, 1997, 27 (09) :1060-1066
[2]   Prednisolone treatment in asthma - Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa [J].
Bentley, AM ;
Hamid, Q ;
Robinson, DS ;
Schotman, E ;
Meng, Q ;
Assoufi, B ;
Kay, AB ;
Durham, SR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (02) :551-556
[3]  
Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9
[4]  
BISSONNETTE EY, 1991, J IMMUNOL, V147, P3060
[5]  
BISSONNETTE EY, 1995, IMMUNOLOGY, V86, P12
[6]  
BISSONNETTE EY, 1990, J IMMUNOL, V145, P3385
[7]   ESTABLISHMENT OF AN IMMATURE MAST-CELL LINE FROM A PATIENT WITH MAST-CELL LEUKEMIA [J].
BUTTERFIELD, JH ;
WEILER, D ;
DEWALD, G ;
GLEICH, GJ .
LEUKEMIA RESEARCH, 1988, 12 (04) :345-355
[8]   INTERFERON-GAMMA BINDS TO EXTRACELLULAR-MATRIX CHONDROITIN-SULFATE PROTEOGLYCANS, THUS ENHANCING ITS CELLULAR-RESPONSE [J].
CAMEJO, EH ;
ROSENGREN, B ;
CAMEJO, G ;
SARTIPY, P ;
FAGER, G ;
BONDJERS, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (09) :1456-1465
[9]   INTERFERON-GAMMA INHIBITS SEROTONIN RELEASE FROM MOUSE PERITONEAL MAST-CELLS [J].
COLEMAN, JW ;
BUCKLEY, MG ;
HOLLIDAY, MR ;
MORRIS, AG .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (10) :2559-2564
[10]  
COLEMAN JW, 1993, J IMMUNOL, V150, P556